Effect of Cranial Stimulation and Acupuncture on Pain, Functional Capability and Cerebral Function in Osteoarthritis
torstai 17. elokuuta 2017 päivittänyt: Hospital de Clinicas de Porto Alegre
Effect of Transcranial Direct Current Stimulation and Electro Acupuncture in Pain, Functional Capability and Cortical Excitability in Patients With Osteoarthritis.
The objective of this study is to evaluate the efficacy of transcranial direct current stimulation (tDCS) and electro acupuncture (EAC) compared to sham treatment in reducing pain, improving functional capacity and functioning of the neuro-immune-endocrine system in patients with chronic pain due to knee osteoarthritis.
Tutkimuksen yleiskatsaus
Tila
Valmis
Interventio / Hoito
Yksityiskohtainen kuvaus
The knee osteoarthritis has high prevalence, which tends to increase with the aging population.
The limited efficacy of pharmacological interventions stimulates the search for other options, in order to increase the therapeutic success.
Acupuncture is widely used for pain control in several pathologies.
A modality of intramuscular stimulation to quantify the intensity of the stimulus is electro acupuncture (EAC) that the intensity of 2 Hz accelerates the release of enkephalins, endorphins and beta-endorphins.
The application of electric currents to modify brain function is a very old technique.
The transcranial direct current stimulation (tDCS) is based on applying transcranial direct weak current (usually above 2mA) through electrodes in a non-invasive, simple and painless.
Other advantages include low cost and the possibility of a placebo reliable.
The purpose of this study is to evaluate the ability to reduce pain and improve functionality in chronic pain for knee osteoarthritis with two techniques, one that promotes a bottom-up approach (EAC) and other top-down (tDCS).
We will seek to analyze the efficacy of them separately and together, seeking summation of results.
Opintotyyppi
Interventio
Ilmoittautuminen (Todellinen)
60
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.
Opiskelupaikat
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasilia, 90035903
- Hospital de Clinicas de Porto Alegre
-
-
Osallistumiskriteerit
Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.
Kelpoisuusvaatimukset
Opintokelpoiset iät
18 vuotta ja vanhemmat (Aikuinen, Vanhempi Aikuinen)
Hyväksyy terveitä vapaaehtoisia
Ei
Sukupuolet, jotka voivat opiskella
Nainen
Kuvaus
Inclusion Criteria:- Provision of informed consent to participate.
- Women with over 18 years old,with chronic pain because of primary osteoarthritis of the knee.
- Pain stable for at least three months. Score greater than or equal to 3 cm (0 cm = "no pain" and "worst possible pain" = 10cm) on Visual Analog Scale (VAS) for pain perception at baseline.
- No contraindications to electroacupuncture, transcranial direct current stimulation or transcranial magnetic stimulation.
Exclusion Criteria:-Clinically significant or unstable disorder, medical or psychiatric.
- Presence of neurological or rheumatic comorbidity.
- Pregnancy.
- Already having been treated with acupuncture.
- Having performed with corticosteroid infiltration in the last six weeks or are using this.
- Having performed with hyaluronic acid infiltration in the last year.
- Previous surgery on the limb to be treated or have surgical program for the next 6 months.
Opintosuunnitelma
Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Active Comparator: tDCS and EAC sham
Subjects will receive 05 sessions of tDCS.
The tDCS consist of application of current of 2 mA, the anode being placed in the motor cortex (M1) and the cathode in the supraorbital region, for 30 minutes,using electrodes with saline solution.
The sham DIMST consist of the use of rubber electrodes placed in the same places that active treatment.
Will use the same electrical apparatus, but without pass of current to the electrodes.
The unit will be in front of the patient on with their lights blinking.
|
The tDCS apparatus is operated on battery power, will be used rubber electrodes soaked in saline solution.
The anode is placed in M1 and the cathode in the supraorbital region.
Muut nimet:
|
|
Placebo Comparator: tDCS sham and EAC sham
The subjects will receive 05 sessions of tDCS sham and EAC sham.
The sham tDCS be performed in the same way as the active, although the Electro device is turned off 30 seconds after the beginning of treatment, the session will have the same duration of 30 minutes.
The EAC sham consists of placement of rubber electrodes in the same areas of active stimulation (beside the spinous processes of L1 to S2, muscles vastus lateralis, rectus anterioris, vastus medialis, tibialis anterior, peroneus longus and insertion of the pes anserinus).
The electrodes are connected to the same device electro, for 30 minutes, but without passage of electrical stimulation to the patient.
The device is kept on and in front of the patient, with the lights blinking.
|
For the EAC sham we will use rubber electrodes.
They will be applied in the same areas of active EAC.
They are connected to the same electroacupuncture device, but without current passing for the patient.
All subjects receive one 30min session.
Muut nimet:
|
|
Active Comparator: tDCS sham and EAC
Subjects will receive 05 sessions of tDCS sham and EAC.The sham tDCS be performed in the same way as the active, although the Electro device is turned off 30 seconds after the beginning of treatment, the session will have the same duration of 30 minutes.
The EAC consist of electrical stimulation with a frequency of 2 Hz for 30 min.
The needles are placed beside the spinous processes of L1 to S2, with a depth of 3 cm and in the muscles: vastus lateralis, rectus anterioris, vastus medialis, tibialis anterior, peroneus longus and insertion of the pes anserinus.
|
For the sham tDCS we will use the same apparatus in the same location, but the current is stopped after 30 seconds.
Muut nimet:
|
|
Kokeellinen: tDCS and EAC
Subjects will receive 05 sessions of transcranial direct current stimulation(tDCS) and electroacupuncture(EAC).
The tDCS consist of application of current of 2 mA, the anode being placed in the motor cortex (M1) and the cathode in the supraorbital region, for 30 minutes,using electrodes with saline.
The electroacupuncture consist of electrical stimulation with a frequency of 2 Hz for 30 min.
The needles are placed beside the spinous processes of L1 to S2, with a depth of 3 cm and in the muscles: vastus lateralis, rectus anterioris, vastus medialis, tibialis anterior, peroneus longus and insertion of the pes anserinus.
|
For the acupuncture we will use needles with guide tubes that are 40 mm in length and 0.25 mm in diameter.
The needling will be applied using an electro acupuncture device in the dermatomes, myotome, or sclerotome corresponding to the nerve roots involved in the knee (L1, L2, L3, L4, L5, S1, and S2).
All patients received one 30min session using a frequency of 2 Hz.
Muut nimet:
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in the intensity of daily pain.
Aikaikkuna: The treatment will be 5 daily sessions.The pain level will be assessed before treatment, after each session and at the end of treatment.Totaling six days.
|
Measurement of outcomes by clinical parameters: Pain - The pain daily, in the course of treatment will be measured by the Visual Analog Scale, (VAS) 10 cm where zero corresponds to no pain and 10 cm maximum pain.
|
The treatment will be 5 daily sessions.The pain level will be assessed before treatment, after each session and at the end of treatment.Totaling six days.
|
|
Change in the pressure pain threshold.
Aikaikkuna: The pressure pain threshold will will be evaluated before and after 5 daily sessions of treatment.Totaling six days.
|
Measurement of outcomes by parameters of pain threshold: Threshold Tolerance Test Algometry Pressure: the tolerance threshold pressure is measured by pressure algometer digital, with an area of 1 cm2 in area with muscle trigger point that triggers more pain.
The maximum pressure to be applied will be 1400 kPa (Kilopascal) to avoid tissue damage.
The patient will be instructed to indicate when the stimulus becomes unbearable and the value of tolerance threshold will be constituted by the average of three measurements.
|
The pressure pain threshold will will be evaluated before and after 5 daily sessions of treatment.Totaling six days.
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
State of physical and mental health.
Aikaikkuna: The state of physical and mental health will be assessed before and after treatment. Totaly five days.
|
The quality of life and health status will be assessed through the WHOQOL ( World Health Organization Quality of Life), reduced form, adapted to Portuguese in Brazil.
The level of catastrophic thinking will be assessed by the scale of catastrophic thoughts.
|
The state of physical and mental health will be assessed before and after treatment. Totaly five days.
|
|
Level of depressive symptoms .
Aikaikkuna: Depressive symptoms will be assessed before and after treatment. Totaly five days.
|
Depressive symptoms are measured by the Beck Depression Scale, which covers neurovegetative symptoms of depression .
|
Depressive symptoms will be assessed before and after treatment. Totaly five days.
|
|
Daily sleep quality.
Aikaikkuna: Sleep quality will be evaluated daily, totaling five days of evaluation.
|
Sleep quality will be assessed with the Pittsburgh Sleep Quality Index and the 10cm scale of sleep quality.
|
Sleep quality will be evaluated daily, totaling five days of evaluation.
|
|
Change in the level of functionality.
Aikaikkuna: The functionality level will be evaluated before and after 5 daily sessions of treatment.Totaling six days.
|
WOMAC(Western Ontario and McMaster Universities Questionnaire) - assessment of pain, stiffness and functional ability.
|
The functionality level will be evaluated before and after 5 daily sessions of treatment.Totaling six days.
|
Muut tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Cortical excitability:Motor threshold (MT), Motor evoked potential (MEP),silent period (SP), intracortical facilitation (ICF)and intracortical inhibition (ICI).
Aikaikkuna: The cortical excitability is evaluated before and after treatment with a transcranial magnetic stimulation (TMS) equipment.
|
MagPro X100 and a figure-of-8 coil centered over the motor cortex (M1).MEP - will be made 10 stimuli with an intensity of 120% of motor threshold (MT).
SP- is determined from the maximum force of adduction of right thumb measured with a dynamometer.
The patient has 20% of maximum strength of adduction of the thumb and it is the stimulus 120% MT of the contralateral hemisphere.
The SP is the time needed to recover 50% of the initial voltage obtained in electromyographic register.
ICF - is investigated by paired pulse.
TMS will be used with expansion module for paired pulse.
Conditioning stimulus intensity is 80% of the MT and the intensity of the stimulus test is 120% of the MT.
The inter-stimulus will be 12 microsec.
ICI - Investigated by paired pulse.
TMS will be used with expansion module for paired pulse.
Conditioning stimulus intensity is 80% of the MT and the intensity of the stimulus test is 120% of the MT.
The inter-stimulus interval is 2 microsec.
|
The cortical excitability is evaluated before and after treatment with a transcranial magnetic stimulation (TMS) equipment.
|
Yhteistyökumppanit ja tutkijat
Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.
Sponsori
Yhteistyökumppanit
Julkaisuja ja hyödyllisiä linkkejä
Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.
Yleiset julkaisut
- Imamura M, Imamura ST, Kaziyama HH, Targino RA, Hsing WT, de Souza LP, Cutait MM, Fregni F, Camanho GL. Impact of nervous system hyperalgesia on pain, disability, and quality of life in patients with knee osteoarthritis: a controlled analysis. Arthritis Rheum. 2008 Oct 15;59(10):1424-31. doi: 10.1002/art.24120.
- Lefaucheur JP, Drouot X, Menard-Lefaucheur I, Keravel Y, Nguyen JP. Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain. Neurology. 2006 Nov 14;67(9):1568-74. doi: 10.1212/01.wnl.0000242731.10074.3c.
- Zaghi S, Thiele B, Pimentel D, Pimentel T, Fregni F. Assessment and treatment of pain with non-invasive cortical stimulation. Restor Neurol Neurosci. 2011;29(6):439-51. doi: 10.3233/RNN-2011-0615.
- Srbely JZ, Dickey JP, Lee D, Lowerison M. Dry needle stimulation of myofascial trigger points evokes segmental anti-nociceptive effects. J Rehabil Med. 2010 May;42(5):463-8. doi: 10.2340/16501977-0535.
- Zunhammer M, Eichhammer P, Franz J, Hajak G, Busch V. Effects of acupuncture needle penetration on motor system excitability. Neurophysiol Clin. 2012 Jun;42(4):225-30. doi: 10.1016/j.neucli.2012.02.134. Epub 2012 Mar 6.
- Lo YL, Cui SL. Acupuncture and the modulation of cortical excitability. Neuroreport. 2003 Jul 1;14(9):1229-31. doi: 10.1097/00001756-200307010-00008.
- Schwenkreis P, Scherens A, Ronnau AK, Hoffken O, Tegenthoff M, Maier C. Cortical disinhibition occurs in chronic neuropathic, but not in chronic nociceptive pain. BMC Neurosci. 2010 Jun 11;11:73. doi: 10.1186/1471-2202-11-73.
- Laste G, Caumo W, Adachi LN, Rozisky JR, de Macedo IC, Filho PR, Partata WA, Fregni F, Torres IL. After-effects of consecutive sessions of transcranial direct current stimulation (tDCS) in a rat model of chronic inflammation. Exp Brain Res. 2012 Aug;221(1):75-83. doi: 10.1007/s00221-012-3149-x. Epub 2012 Jul 3.
- Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain. 1979 Jun;6(3):305-327. doi: 10.1016/0304-3959(79)90050-2.
- Lima MC, Fregni F. Motor cortex stimulation for chronic pain: systematic review and meta-analysis of the literature. Neurology. 2008 Jun 10;70(24):2329-37. doi: 10.1212/01.wnl.0000314649.38527.93.
- Boggio PS, Amancio EJ, Correa CF, Cecilio S, Valasek C, Bajwa Z, Freedman SD, Pascual-Leone A, Edwards DJ, Fregni F. Transcranial DC stimulation coupled with TENS for the treatment of chronic pain: a preliminary study. Clin J Pain. 2009 Oct;25(8):691-5. doi: 10.1097/AJP.0b013e3181af1414.
- da Graca-Tarrago M, Lech M, Angoleri LDM, Santos DS, Deitos A, Brietzke AP, Torres IL, Fregni F, Caumo W. Intramuscular electrical stimulus potentiates motor cortex modulation effects on pain and descending inhibitory systems in knee osteoarthritis: a randomized, factorial, sham-controlled study. J Pain Res. 2019 Jan 3;12:209-221. doi: 10.2147/JPR.S181019. eCollection 2019.
Opintojen ennätyspäivät
Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan julkisella verkkosivustolla.
Opi tärkeimmät päivämäärät
Opiskelun aloitus
Lauantai 1. maaliskuuta 2014
Ensisijainen valmistuminen (Todellinen)
Tiistai 1. maaliskuuta 2016
Opintojen valmistuminen (Todellinen)
Torstai 1. joulukuuta 2016
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Maanantai 15. lokakuuta 2012
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Maanantai 10. joulukuuta 2012
Ensimmäinen Lähetetty (Arvio)
Tiistai 11. joulukuuta 2012
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Tiistai 22. elokuuta 2017
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Torstai 17. elokuuta 2017
Viimeksi vahvistettu
Tiistai 1. elokuuta 2017
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- 110013
- U1111-1130-1855 (Muu tunniste: UTN)
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
PÄÄTTÄMÄTÖN
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .